Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Characterization of murine Caraparu Bunyavirus liver infection and immunomodulator-mediated antiviral protection.

Brinton MA, Gavin EI, Lo WK, Pinto AJ, Morahan PS.

Antiviral Res. 1993 Feb;20(2):155-71.

PMID:
8460932
2.

In vitro and in vivo studies of the Interferon-alpha action on distinct Orthobunyavirus.

Livonesi MC, de Sousa RL, Badra SJ, Figueiredo LT.

Antiviral Res. 2007 Aug;75(2):121-8. Epub 2007 Feb 28.

PMID:
17368573
3.

In vitro and in vivo studies of ribavirin action on Brazilian Orthobunyavirus.

Livonesi MC, De Sousa RL, Badra SJ, Figueiredo LT.

Am J Trop Med Hyg. 2006 Nov;75(5):1011-6.

PMID:
17124004
4.
5.

Antiviral and immunomodulating inhibitors of experimentally-induced Punta Toro virus infections.

Sidwell RW, Huffman JH, Barnard DL, Smee DF, Warren RP, Chirigos MA, Kende M, Huggins J.

Antiviral Res. 1994 Oct;25(2):105-22.

PMID:
7847873
6.

Varying role of alpha/beta interferon in the antiviral efficacy of synthetic immunomodulators against Semliki Forest virus infection.

Morahan PS, Pinto A, Stewart D, Murasko DM, Brinton MA.

Antiviral Res. 1991 Mar-Apr;15(3):241-54.

PMID:
1653557
7.
8.
9.

[Effect of ribavirin on bunyavirus reproduction in cell culture and in an experiment on white mice].

Berezina LK, Leont'eva NA, Kondrashina NG, L'vov DK, Gagelov GA.

Vopr Virusol. 1983 Sep-Oct;28(5):627-9. Russian. No abstract available.

PMID:
6419466
10.

Prophylactic and therapeutic intervention of Punta Toro virus (Phlebovirus, Bunyaviridae) infection in hamsters with interferon alfacon-1.

Gowen BB, Wong MH, Jung KH, Blatt LM, Sidwell RW.

Antiviral Res. 2008 Mar;77(3):215-24. doi: 10.1016/j.antiviral.2007.12.002. Epub 2008 Jan 7.

11.

Interferon-Regulatory Factor 5-Dependent Signaling Restricts Orthobunyavirus Dissemination to the Central Nervous System.

Proenca-Modena JL, Hyde JL, Sesti-Costa R, Lucas T, Pinto AK, Richner JM, Gorman MJ, Lazear HM, Diamond MS.

J Virol. 2015 Oct 14;90(1):189-205. doi: 10.1128/JVI.02276-15. Print 2016 Jan 1.

12.

Interferons and ribavirin effectively inhibit Norwalk virus replication in replicon-bearing cells.

Chang KO, George DW.

J Virol. 2007 Nov;81(22):12111-8. Epub 2007 Sep 12.

13.
14.

Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy.

Okuse C, Rinaudo JA, Farrar K, Wells F, Korba BE.

Antiviral Res. 2005 Jan;65(1):23-34.

PMID:
15652968
15.

Synergistic antiviral effect of a combination of mouse interferon-alpha and interferon-gamma on mouse hepatitis virus.

Fuchizaki U, Kaneko S, Nakamoto Y, Sugiyama Y, Imagawa K, Kikuchi M, Kobayashi K.

J Med Virol. 2003 Feb;69(2):188-94.

PMID:
12683406
16.

Antiviral Activities of Different Interferon Types and Subtypes against Hepatitis E Virus Replication.

Todt D, Fran├žois C, Anggakusuma, Behrendt P, Engelmann M, Knegendorf L, Vieyres G, Wedemeyer H, Hartmann R, Pietschmann T, Duverlie G, Steinmann E.

Antimicrob Agents Chemother. 2016 Mar 25;60(4):2132-9. doi: 10.1128/AAC.02427-15. Print 2016 Apr.

17.
19.

Modulation of Potassium Channels Inhibits Bunyavirus Infection.

Hover S, King B, Hall B, Loundras EA, Taqi H, Daly J, Dallas M, Peers C, Schnettler E, McKimmie C, Kohl A, Barr JN, Mankouri J.

J Biol Chem. 2016 Feb 12;291(7):3411-22. doi: 10.1074/jbc.M115.692673. Epub 2015 Dec 16.

20.

Anti-influenza virus effects of crude phenylethanoid glycosides isolated from ligustrum purpurascens via inducing endogenous interferon-╬│.

Hu XP, Shao MM, Song X, Wu XL, Qi L, Zheng K, Fan L, Liao CH, Li CY, He J, Hu YJ, Wu HQ, Li SH, Zhang J, Zhang FX, He ZD.

J Ethnopharmacol. 2016 Feb 17;179:128-36. doi: 10.1016/j.jep.2015.07.019. Epub 2015 Jul 17.

PMID:
26190352

Supplemental Content

Support Center